drugset / Trial / NCT05782816

Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor

NCT05782816

Phase 4 Completed 170 enrolled The University of Texas Medical Branch, Galveston
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to compare oxytocin infusion rates for induction and augmentation of labor in nulliparous women. The main question\[s\] it aims to answer are: * Does a high dose oxytocin infusion protocol affect length of induction to delivery interval? * Does a high dose oxytocin infusion protocol affect mode of delivery? * Does a high dose oxytocin infusion protocol affect maternal and neonatal outcomes? Participants will be randomized to either low- or high-dose oxytocin groups: * The low dose group will receive an infusion to start at 2 milli-units/min and will be increased by 2 milli-units/min every 20 minutes. The maximum rate of infusion is 40 milli-units/min. * The high dose group will receive an infusion to start at 6 milli-units/min and will be increased by 6 milli-units/min every 20 minutes. Maximum rate of infusion is 40 milli-units/min.

Timeline

Start
2023-04-17
Primary completion
2024-12-31
Completion
2025-06-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 2 unknown Intravenous
Comparator Oxytocin Peptide 6 unknown Intravenous

Indications

No indication recorded.